Suppression of transcription factor NF-κB activity by Bcl-2 protein in NIH3T3 cells: Implication of a novel NF-κB p50-Bcl-2 complex for the anti-apoptotic function of Bcl-2

European Journal of Cell Biology

Volumn 79, Issue 2, 2000, Pages 121-129

  Hour, Tzyh Chyuan ^a   Chen, Linda ^a   Lin, Jen Kun ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Apoptosis; Bcl 2; NF B; NIH3T3 cells; S nitrosoglutathione

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN BCL 2; S NITROSOGLUTATHIONE;

ANIMAL CELL; APOPTOSIS; ARTICLE; BINDING SITE; CELL NUCLEUS; COMPLEX FORMATION; CONTROLLED STUDY; CYTOPLASM; DNA BINDING; FIBROBLAST CULTURE; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; MOUSE; NONHUMAN; ONCOGENE C MYC; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALIA;

EID: 0034090212     PISSN: 01719335     EISSN: None     Source Type: Journal    
DOI: 10.1078/S0171-9335(04)70014-X     Document Type: Article

References (49)

1. Ameisen, J. C. (1994): Programmed cell death (apoptosis) and cell survival regulation: relevance to AIDS and cancer. AIDS (Phila) 8. 1197-1213.
2. Baeuerle, P. A., Henkel, T. (1994): Function and activation of NF-κB in the immune system. Annu. Rev. Immunol 12, 141-179.
3. Bissonnette, R. P., Echeverri, F., Mahboubi, A., Green, D. R. (1992): Apoptosis cell death induced by c-myc is inhibited by bcl-2. Nature 359, 552-554.
4. Brown, K., Gerstberger, S., Carlson, L., Franzoso, G., Siebenlist, U. (1995): Control of IkBa proteolysis by site-specific, signal-induced phosphorylation. Science 267, 1485-1488.
5. Casano, F. J., Rolando, A. M. Mudgett, J. S., Molineaux, S. M. (1994): The structure and complete nucleotide sequence of the murine gene encoding interleukin-lb converting enzyme (ICE). Genomics 20, 474-481.
6. Chen, F., Kuh, D., Sun, S. C., Gaydos, L. J., Demers, L. M. (1995): Dependence and reversal of nitric oxide production on NF-κB in silica and lipopolysaccharide-induced macrophages. Biochem. Biophys. Res. Commun. 214, 839-846.
7. Chen, Z. J., Parent, L., Maniatis, T. (1996): Site-specific phosphorylation of IκBα by a novel ubiquitination-dependent protein kinase activity. Cell 84, 853-862.
8. Chen-Levy, Z., Nourse, J., Cleary, M. L. (1989): The Bcl-2 candidate proto-oncogene product is a 24-kilodalton integral-membrane protein highly expressed in lymphoid cell lines and lymphomas carrying the t (14:18). Mol. Cell. Biol. 9, 701-710.
9. Didonato, J., Mercurio, F., Rosette, C. Wu-Li, J., Suyang, H., Ghosh, S., Karin, M. (1996): Mapping of the inducible IκB phosphorylation sites that signal its ubiquitination and degradation. Mol. Cell. Biol. 16, 1295-1304.
10. Ellis, R. E. (1991): Mechanisms and function of cell death. Annu. Rev. Cell Biol. 7, 663-668.
11. Fernandez-Sarabia, M. J., Bischoff, J. R. (1993): Bcl-2 associates with the ras-related protein R-ras P23. Nature (Lond) 266, 274-275.
12. Gajewski, T. F., Thompson, C.B. (1996): Apoptosis meets signal transduction: elimination of a BAD influence. Cell 87, 589-592.
13. Gilmore, T. D., Koedood, M., Piffat, K. A., White, D. W. (1996): Rel/ NF-κB IκB proteins and cancer. Oncogene 13, 1367-1378.
14. Grimm, S., Bauer, M. K. A., Baeuerle, P. A., Schulze-Osthoff, K. (1996): Bcl-2 down-regulates the activity of transcription factor NF-κB induced upon apoptosis. J. Cell Biol. 134, 13-23.
15. Henkel, T., Machleidt, T., Alkalay, I., Krönke, M., Ben-Neriah, Y., Baeuerle, P.A. (1993): Rapid proteolysis of IκBa is necessary for activation of transcription factor NF-κB. Nature 365, 182-185.
16. Hockenbery, D. M., Nunez, G., Milliman, C., Schreiber, R. D., Korsmeyer, S. J. (1990): Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 348, 334-336.
17. Hockenbery. D.M., Otvai, Z. N., Yin, X. M., Milliman, C. L., Korsmeyer, S. J. (1993): Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 75, 241-251.
18. Ivanov, V. N., Deng, G., Podack, E. R., Malek, T. R. (1995): Pleiotropic effects of Bcl-2 on transcription factors in T cells: potential role of NF-κB p50-p50 for the anti-apoptotic function of Bcl-2. Int. Immunol. 7, 1709-1720.
19. Jacobson, M. D., Burnett, J. F. King, M. D., Miyashita, T., Reed, J. C., Raff, M. C. (1993): Bcl-2 blocks apoptosis in cells lacking mitochondrial DNA. Nature 361, 365-369.
20. Kane, D. J., Sarafian, T. A., Anton, R., Hahn, H., Gralla, E. B., Valentine, J. S., Ord, T., Bredesen, D. E. (1993): Bcl-2 inhibition of neural death: decreased generation of reactive oxygen species. Science 262, 1274-1277.
21. Kerr, J. F. R., Winterford, C. M., Harmon, B. V. (1994): Apoptosis: its significance in cancer and cancer therapy. Cancer 73, 2013-2026.
22. Korsmeyer, S. J. (1992): Bcl-2 initiates a new category of oncogenes: regulators of cell death. Blood 80, 879-886.
23. La Rose, F. A., Pierce, J. W., Sonenshein, G. E. (1994): Differential regulation of the c-myc oncogene promoter by the NF-κB Rel family of transcription factors. Mol. Cell Biol. 14, 1039-1044.
24. Lee, B. H., Arsura, M., Wu, M., Duyao. M., Buckler. A. J., Sonenshein, G. E. (1995): Role of Rel-related factors in control of c-myc gene transcription in receptor-mediated apoptosis of the murine B cell WEHI 231 line. J. Exp. Med. 181, 1169-1177.
25. Mebmer, U K., Reed, J. C., Brüne, B. (1996): Bcl-2 protects macrophages from nitric oxide-induced apoptosis. J. Biol. Chem. 271, 20192-20197.
26. Mercurio, F., Zhu, H., Murray, B. W., Shevchenko, A., Bennett, Li, J., Young, D. B., Barbosa, M., Mann, M., Manning, A., Rao, A. (1997): IKK-1 and IKK-2: cytokine-activated IκB kinases essential for NF-κB activation. Science 278, 860-866.
27. Monaghan, P., Robertson, D., Amos, T. A. S., Dyer, M. J. S., Mason, D. Y., Greaves, M. F. (1992): Ultrastructural localization of Bcl-2 protein. J. Histochem. Cytochem, 40, 1819-1825.
28. Nunez, G., Clarke, M. F. (1994): The Bcl-2 family of proteins: regulators of cell death and survival. Trends Cell Biol. 4, 399-403.
29. Obeid, L. M., Linardic, C. M., Karolak, L. A., Hannun, Y. A. (1993): Programmed cell death induced by ceramide. Science 259, 1769-1771.
30. Osborn, L., Kunkel, S., Nabel, G. J. (1989): Tumor necrosis factor alpha and interleukin-1 stimulate the human immunodeficiency virus enhancer by activation of nuclear factor kappa B. Proc. Natl. Acad. Sci. USA 86, 2336-2340.
31. Reed, J. C. (1994): Bcl-2 and the regulation of programmed cell death. J. Cell Biol. 124. 1-6.
32. Schauer, S. L., Wang, Z., Sonenshein, G. E., Rothstein, T. L. (1996): Maintenance of nuclear factor-κ-B/Rel and c-myc expression during CD40 ligand rescue of WEHI 231 early B cell from receptor-mediated apoptosis through modulation of IκB proteins. J. Immunol. 157, 81-86.
33. Schreck, R., Rieber, P., Bacuerle, P.A. (1991): Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-κB transcription factor and HIV-1. EMBO J. 10, 2247-2258.
34. Schulze-Osthoff, K., Bauer, M. K. A., Vogt, M., Los, M. (1996): Involvement of ICE-related and other protease in Fas-mediated apoptosis. Cell Death Differ. 3, 177-184.
35. Schülze, S., Potthoff, K., Machleidt, T., Berkovic, D., Wiegmann, K., Krönke, M. (1992): TNF activates NF-κB by phophatidylcholine-specific phospholipase c-induced "acidic" sphingomyelin breakdown. Cell 71, 765-776.
36. Schwartz, L. M., Osborne, B. A. (1993): Programmed cell death, apoptosis and Killer genes. Immunol. Today 14, 582-590.
37. Seto, M., Jaeger, V., Hockett, R., Graninger, W., Bennett, S., Goldman, P., Korsmeyer, S. J. (1988): Alternative promoters and exons, somatic mutation and deregulation of Bcl-2-Ig fusing gene in lymphoma. EMBO J. 7, 123-131.
38. Shimizu, S., Eguchi, Y., Kamiike, W., Matsuda, H., Tsujimoto, Y. (1996): Bcl-2 expression prevents activation of the ICE protease cascade. Oncogene 12, 2251-2257.
39. Siebenlist, U., Franzoso, G., Brown, K. (1994): Structure regulation and function of NF-κB. Annu. Rev. Cell Biol. 10, 405-455.
40. Suda, T., Takahashi, T., Golstein, P., Nagata, S. (1993): Molecular cloning and expression of the Fas ligand, a novel member of tumor necrosis factor family. Cell 75, 1169-1178.
41. Takahashi, T. Tanaka, M., Inazawa, J., Abe, T., Suda, T., Nagata, S. (1994): Human Fas ligand: gene structure, chromosomal localization and species specificity. Int. Immunol. 6, 1567-1574.
42. Thanos, D., Maniatis, T. (1995): NF-κB: a lesson in family values. Cell 80, 529-532.
43. Tsujimoto, Y., J. Cossman, J., B. Jaffe, B., C. M. Croce, C. M. (1985): Involvement of the bcl-2 gene in human follicular lymphoma. Science 288, 1440-1443.
44. Vaux, D. L. (1993): Toward an understanding of the molecular mechanism of physiological cell death. Proc. Natl. Acad. Sci. USA 90, 786-789.
45. Verma, I. M., Stevenson, E. M., Van, A. D., Miyamoto, S. (1995): Rel/ NF-κB/ IκB family: intimate tales of association and dissociation. Genes Dev. 9, 2723-2735.
46. Woronicz, J. D., Gao, X., Cao, Z., Rothe, M., Goeddel, D. V. (1997): IκB kinase-b: NF-κB activation and complex formation with IκB kinase-α and NIK. Science 278, 866-869.
47. Wu, H., Lozano, G. (1994): NF-κB activation of p53. A potential mechanism for suppressing cell growth in response to stress. J. Biol. Chem. 269, 20067-20074.
48. Yang, E., Korsmeyer, S. J. (1996): Molecular Thanatosis: A discourse in the Bcl-2 family and cell death. Blood 88, 386-401.
49. Zhong, H., SuYang, H., Erdjument-Bromage, H., Tempst, P., Ghosh, S. (1997): The transcriptional activity of NF-κB is regulated by the IκB-associated PKAc subunit through a cyclic AMP-independent mechanism. Cell 89, 413-424.